Sun Pharma is recalling over 2.7 lakh bottles of bupropion hydrochloride extended-release tablets used for treatment of major depressive disorder in the US due to failed dissolution specifications.
Over 20,500 bottles of anti- depressant Bupropion Hydrochloride extended release tablets made by Cadila Healthcare are being recalled by Amerisource Health Services for failed dissolution specifications.
The recall has been initiated by Sun Pharmaceutical Industries Inc for 31,762 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strength of 150 mg, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.